- Home
- About Us
- Divisions
- Adolescent and Young Adult Medicine
- Allergy and Immunology
- Cardiology
- Child Advocacy
- Emergency Medicine
- Endocrinology
- Gastroenterology, Hepatology and Nutrition
- General Academic Pediatrics
- Genetic and Genomic Medicine
- Health Informatics
- Pediatric Hematology, Oncology, and Stem Cell Transplantation
- Infectious Diseases
- Nephrology
- Neurology and Child Development
- Newborn Medicine
- Paul C. Gaffney Division of Pediatric Hospital Medicine
- Pulmonology
- Rheumatology
- Centers & Institutes
- Center for Pediatric Research in Obesity and Metabolism
- Center for Rare Disease Therapy
- Children's Center for Neurogenomics
- Children's Neuroscience Institute
- Cystic Fibrosis Research Center
- Institute for Infection, Inflammation, and Immunity in Children
- Pediatric Asthma Center
- Richard King Mellon Foundation Institute for Pediatric Research
- Pittsburgh Vaccine Trials Unit
- The Pittsburgh Study
- CHAMP: Career Help Advancement and Achievement Mentorship Program
- The Genetics, Genomics, and Growth Center
- Faculty Development
- Engagement
- Research
- Education
- Residencies
- Fellowships
- Continuing Medical Education
- Medical Student Education and Training
- Principal Investigator Labs
- Maintenance of Certification Portfolio Program
- Summer Research Internship
- Kidney Workshop (SRIP-Kid)
- Cardiology, Hematology, and Pulmonology (CHP) Summer Research Internship Program (CHP2SRIP)
- Hematoloy-Oncology (Hem/Onc)
- Endocrinology, Diabetes & Metabolism (Endo)
- Neurology, Child Development & Neuroscience (Neuro)
- Genetics & Genomic Medicine (GGM)
- Adolescent and Young Adult Medicine & General Academic Pediatrics (AMP)
- Infectious Diseases, Allergy & Immunology (IDAI)
- Directory
- Physician Scientist Training Programs
- News
- People
- Podcasts
Sawalha Lab
Our research program focuses on elucidating genetic and epigenetic contribution to the pathogenesis of systemic autoimmune and inflammatory rheumatic diseases. We apply state-of-the-art genomic, epigenomic, and bioinformatics methodologies, and subsequent functional studies using both in vitro and in vivo systems to identify and characterize genetic loci and pathways involved in the pathogenesis of immune-mediated diseases. Using careful clinical phenotyping and extensive national and international collaborations, we aim at discovering genomic and epigenomic markers for disease progression, specific organ involvement, and response to therapy in systemic autoimmunity.
Our Focus Areas
- Novel discoveries in the genetic and epigenetic causation of complex autoimmune diseases
- Functional characterization of these novel findings to provide mechanistic insights into disease pathogenesis
- Development of genetic and epigenetic biomarkers of disease severity, activity, response to therapy, and phenotypic progression